Bruker Corporation

As of June 30, 2026, Bruker Corporation carries a market capitalization of 9.17B, placing it among publicly traded companies globally. Its enterprise value stands at 10.83B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Bruker Corporation's next confirmed earnings release is scheduled for November 4, 2026.

As of June 30, 2026, Bruker Corporation has 152.35M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 2.62, and the price-to-book ratio stands at 3.85.

As of June 30, 2026, Bruker Corporation trades at an EV/EBITDA multiple of 54.26 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 3.09 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 10.83B versus a market cap of 9.17B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Bruker Corporation maintains a current ratio of 1.85, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 74.92, indicating elevated leverage, while an interest coverage ratio of 3.24 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Bruker Corporation posted a negative return on equity (ROE) of -5.11, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -1.15, reflecting losses generated across the asset base. The company generates approximately 313,506.98 in revenue per employee across its workforce of 11,162.75, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.60 indicates how many times Bruker Corporation sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Bruker Corporation recorded 40.40M in income tax expense. The company reported a pretax loss of -22.40M and -71.20M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 27, 2026, Bruker Corporation's stock has gained approximately 57.19% over the past 52 weeks. The 50-day moving average sits at 58.79, while the 200-day moving average is 50.08.

Over the twelve months ended June 30, 2026, Bruker Corporation generated 3.50B in revenue and converted that into -71.20M in net income, yielding earnings per share of -0.42. EBITDA reached 199.50M, while operating income came in at 266.00M.

As of June 30, 2026, Bruker Corporation holds 222.50M in cash and equivalents against 1.82B in total debt, resulting in a net debt position of 1.64B. Total book value stands at 2.38B, with working capital of 1.02B providing operational flexibility.

Bruker Corporation produced 190.40M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -96.50M in capital expenditures, free cash flow totaled 93.90M - equivalent to 0.62 per share.

Over the twelve months ended June 30, 2026, Bruker Corporation posted a gross margin of 46.42, reflecting its pricing power and cost economics. The operating margin of 7.60 and net profit margin of -2.03 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Bruker Corporation paid dividends of 0.36 per share. The dividend payout ratio of -20.32 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 1.02, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -0.38, meaning Bruker Corporation raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Bruker Corporation has an Altman Z-Score of 3.87, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.